Epithelial expression and release of FGF-2 from heparan sulphate binding sites in bronchial tissue in asthma

Thorax

Volumn 59, Issue 7, 2004, Pages 557-562

  Shute, J K ^a,b   Solic, N ^b   Shimizu, J ^b   McConnell, W ^b   Redington, A E ^b   Howarth, P H ^b  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GLYCOSIDASE; HEPARIN; PROTEOHEPARAN SULFATE;

ARTICLE; ASTHMA; BASEMENT MEMBRANE; BINDING SITE; BRONCHUS; BRONCHUS MUCOSA; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; EXAMINATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SOLUBILIZATION;

ADULT; ASTHMA; BINDING SITES; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; EPITHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 2; FORCED EXPIRATORY VOLUME; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN LYASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 3; STREPTOKINASE;

EID: 3142590620     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2002.002626     Document Type: Article

References (32)

1. Roche WR, Beasley R, Williams JH, et al. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;i:520-4.
2. Brewster CEP, Howarth PH, Djukanovic R, et al. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990;3:507-11.
3. Bikfalvi A, Klein S, Pintucci G, et al. Biological roles of fibroblast growth factor-2. Endocrin Rev 1997;18:26-45.
4. Mason LJ. The ins and outs of fibroblast growth factors. Cell 1994;78:547-52.
5. Lander AD, Selleck SB. The elusive functions of proteoglycans: in vivo veritas. J Cell Biol 2000;148:227-32.
6. Bernfield M, Gotte M, Park P-Y, et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999;68:729-77.
7. Iozzo RV, Murdoch AD. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J 1996;10:598-614.
8. Aviezer D, Hecht D, Safran M, et al. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 1994;79:1005-13.
9. Flaumenhaft R, Moscatelli D, Saksela O, et al. Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Physiol 1989;140:75-81.
10. Westergren-Thorsson G, Chakir J, Lafrenière-Allard M-J, et al. Correlation between airway responsiveness and proteoglycan production by bronchial fibroblasts from normal and asthmatic subjects. Int J Biochem Cell Biol 2002;34:1256-67.
11. Cordon-Cardo C, Vlodavsky I, Haimovitz-Friedman A, et al. Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 1990;63:832-40.
12. Folkman J, Klagsbrun M, Sasse J, et al. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Pathol 1988;130:393-400.
13. Saksela O, Rifkin DB. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated protealytic activity. J Cell Biol 1990;110:767-75.
14. Benezra M, Vlodavsky I, Ishai-Michaeli R, et al. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. Blood 1993;81:3324-31.
15. Ishai-Michaeli R, Eldor A, Vlodavsky I. Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul 1990;1:833-42.
16. Bashkin P, Doctrow S, Klagsbrun M, et al. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 1989;28:1737-43.
17. Redington AE, Roche WR, Madden J, et al. Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol 2001;107:384-7.
18. Djukanovic R, Wilson JW, Lai CKW, et al. The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am Rev Respir Dis 1991;143:772-7.
19. Chai H, Farr RS, Froehlich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-7.
20. National Heart Lung and Blood Institute: Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases. J Allergy Clin Immunol 1991;88:808-14.
21. Britten KM, Howarth PH, Roche WR. Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem 1993;68:271-80.
22. David G, Bai XM, Van Der Schueren B, et al. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 1992;119:961-75.
23. Dahlen B, Shute J, Howarth P. Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma. Thorax 1999;54:590-6.
24. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001;107:295-301.
25. Rosenberg RD, Schworak NW, Liu J, et al. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest 1997;99:2062-70.
26. Jackson DG. Human leucocyte heparan sulphate proteoglycans and their roles in inflammation. Biochem Soc Trans 1997;25:220-4.
27. Shimada K, Ozawa T. Subendothelial extracellular-matrix heparon sulfate proteoglycan-degrading activity of human monocyte macrophages. Heart Vessels 1987;3:175-81.
28. Fannon M, Forsten KE, Nugent MA. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. Biochemistry 2000;39:1434-45.
29. Green WF, Konnaris K, Woolcock AJ. Effect of salbutamol, fenoterol, and sodium cromoglycate on the release of heparin from sensitized lung tissue fragments challenged with Dermatophagoides pteronyssinus allergen. Am J Respir Cell Mol Biol 1993;8:518-21.
30. Richardson TP, Trinkhaus-Randall V, Nugent MA. Regulation of basic fibroblast growth factor binding and activity by cell density and heparan sulfate. J Biol Chem 1999;274:13534-40.
31. Kato M, Wang H, Kainulainen V, et al. Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat Med 1998;4:691-7.
32. Pender SLF, Lionetti P, Murch SH, et al. Proteolytic degradation of intestinal mucosal extracellular matrix after lamina propria T cell activation. Gut 1996;39:284-90.